Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells

Carcinogenesis

Volumn 26, Issue 1, 2005, Pages 109-117

  Goulet, Anne Christine ^a   Chigbrow, Marianne ^a   Frisk, Peter ^a   Nelson, Mark A ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLIN B; CYCLIN DEPENDENT KINASE 2; HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE; SELENOMETHIONINE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; COLON CANCER; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN B; CYCLIN-DEPENDENT KINASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HCT116 CELLS; HISTONES; HUMANS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SELENOMETHIONINE;

EID: 13444293451     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh306     Document Type: Article

References (57)

1. Frank D.H., Roe,D.J., Chow,H.H., Guillen,J.M., Choquette,K., Gracie,D., Francis,J., Fish,A. and Alberts,D.S. (2004) Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial. Cancer Epidemiol. Biomarkers Prev., 13, 299-303.
2. Clark,L.C., Combs,G.F. Jr, Turnbull,B.W. et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J. Am. Med. Assoc., 276, 1957-1963.
3. Ip,C., Birringer,M., Block,E., Kotrebai,M., Tyson,J.F., Uden,P.C. and Lisk,D.J. (2000) Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J. Agric. Food Chem., 48, 2062-2070.
4. Daniels,L.A. (1996) Selenium metabolism and bioavailability. Biol. Trace Elem. Res., 54, 185-199.
5. Ip,C., Lisk,D.J. and Ganther,H.E. (1998) Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. Anticancer Res., 18, 4019-4025.
6. Ip,C. (1998) Lessons from basic research in selenium and cancer prevention. J. Nutr., 128, 1845-1854.
7. Ip,C. and Ganther,H.E. (1990) Activity of methylated forms of selenium in cancer prevention. Cancer Res., 50, 1206-1211.
8. Ip,C. and Ganther,H.E. (1991) Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis, 12 365-367.
9. Ip,C., Hayes,C., Budnick,R.M. and Ganther,H.E. (1991) Chemical form of selenium, critical metabolites and cancer prevention. Cancer Res., 51, 595-600.
10. Tang,D., Wu,D., Hirao,A., Lahti,J.M., Liu,L., Mazza,B., Kidd,V.J., Mak,T.W. and Ingram,A.J. (2002) ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem., 277, 12710-12717.
11. Wang,Z., Zhang,B., Wang,M. and Carr,B.I. (2003) Persistent ERK phosphorylation negatively regulates cAMP response element-binding protein (CREB) activity via recruitment of CREB-binding protein to pp90RSK. J. Biol. Chem., 278, 11138-11144.
12. Lo,W.S., Trievel,R.C., Rojas,J.R., Duggan,L., Hsu,J.Y., Allis,C.D., Marmorstein,R. and Berger,S.L. (2000) Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol. Cell, 5 917-926.
13. Rea,S., Eisenhaber,F., O'Carroll,D. et al. (2000) Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature, 406, 593-599.
14. Strahl,B.D. and Allis,C.D. (2000) The language of covalent histone modifications. Nature, 403, 41-45.
15. Clayton,A.L. and Mahadevan,L.C. (2003) MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett., 546, 51-58.
16. Hendzel,M.J., Wei,Y., Mancini,M.A., Van Hooser,A., Ranalli,T., Brinkley,B.R., Bazett-Jones,D.P. and Allis,C.D. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360.
17. Hsu,J.Y., Sun,Z.W., Li,X. et al. (2000) Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell, 102 279-291.
18. Bhattacharyya,N.P., Skandalis,A., Ganesh,A., Groden,J. and Meuth,M. (1994) Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl Acad. Sci. USA, 91, 6319-6323.
19. Oki,E., Oda,S., Maehara,Y. and Sugimachi,K. (1999) Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncogene, 18, 2143-2147.
20. Wheeler,J.M., Beck,N.E., Kim,H.C., Tomlinson,I.P., Mortensen,N.J. and Bodmer,W.F. (1999) Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. Proc. Natl Acad. Sci. USA, 96, 10296-10301.
21. Herman,J.G., Umar,A., Polyak,K. et al. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA, 95, 6870-6875.
22. Redman,C., Scott,J.A., Baines,A.T., Basye,J.L., Clark,L.C., Calley,C., Roe,D., Payne,C.M. and Nelson,M.A. (1998) Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett., 125, 103-110.
23. Redman,C., Xu,M.J., Peng,Y.M., Scott,J.A., Payne,C., Clark,L.C. and Nelson,M.A. (1997) Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis, 18, 1195-1202.
24. Krishan,A. (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol., 66, 188-193.
25. Chigbrow,M. and Nelson,M. (2001) Inhibition of mitotic cyclin B and cdc2 kinase activity by selenomethionine in synchronized colon cancer cells. Anticancer Drugs, 12, 43-50.
26. Miura,Y., Thoburn,C.J., Bright,E.C., Chen,W., Nakao,S. and Hess,A.D. (2002) Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Blood 100, 2650-2658.
27. Furnari,B., Blasina,A., Boddy,M.N., McGowan,C.H. and Russell,P. (1999) Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1. Mol. Biol. Cell, 10, 833-845.
28. Leach,S.D., Scatena,C.D., Keefer,C.J., Goodman,H.A., Song,S.Y., Yang,L. and Pietenpol,J.A. (1998) Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res., 58, 3231-3236.
29. Takenaka,K., Moriguchi, T. and Nishida,E. (1998) Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science, 280, 599-602.
30. Roux,P.P., Richards,S.A. and Blenis,J. (2003) Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell. Biol., 23, 4796-4804.
31. Soloaga,A., Thomson,S., Wiggin,G.R., Rampersaud,N., Dyson,M.H., Hazzalin,C.A., Mahadevan,L.C. and Arthur,J.S. (2003) MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of historic H3 and HMG-14. EMBO J., 22, 2788-2797.
32. Sassone-Corsi,P., Mizzen,C.A., Cheung,P., Crosio,C., Monaco,L., Jacquot,S., Hanauer,A. and Allis,C.D. (1999) Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science, 285, 886-891.
33. Jemal,A., Murray,T., Samuels,A., Ghafoor,A. and Thomas,M.J. (2004) Cancer Statistics 2004. CA Cancer J. Clin., 54, 8-29.
34. Dashwood,R.H. (1999) Early detection and prevention of colorectal cancer (review). Oncol. Rep., 6, 277-281.
35. Rennert,G., Rennert,H.S., Miron,E. and Peterburg,Y. (2001) Population colorectal cancer screening with fecal occult blood test. Cancer Epidemiol. Biomarkers Prev., 10, 1165-1168.
36. Ore,L., Hagoel,L., Lavi,I. and Rennert,G. (2001) Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur. J. Cancer Prev. 10, 251-256.
37. Winawer,S.J., Zauber,A.G., Ho,M.N. et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med., 329, 1977-1981.
38. Winawer,S.J., Zauber,A.G., O'Brien,M.J. et al. (1993) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N. Engl. J. Med., 328, 901-906.
39. Citarda,F., Tomaselli,G., Capocaccia,R., Barcherini,S. and Crespi,M. (2001) Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut, 48, 812-815.
40. Thiis-Evensen,E., Hoff,G.S., Sauar,J., Langmark,F., Majak,B.M. and Vatn,M.H. (1999) Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand. J. Gastroenterol., 34, 414-420.
41. Hixson,L.J., Fennerty,M.B., Sampliner,R.E., McGee,D. and Garewal,H. (1990) Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J. Natl Cancer Inst., 82, 1769-1772.
42. Menter,D.G., Sabichi,A.L. and Lippman,S.M. (2000) Selenium effects on prostate cell growth. Cancer Epidemiol. Biomarkers Prev. 9, 1171-1182.
43. Ni,J., Chen,M., Zhang,Y., Li,R., Huang,J. and Yeh,S. (2003) Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem. Biophys. Res. Commun., 300, 357-363.
44. Meuillet,E., Stratton,S., Prasad Cherakuri,D., Goulet,A.C., Kagey,J., Porterfield,B. and Nelson,M.A. (2004) Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings. J. Cell. Biochem., 91, 443-458.
45. Reid,M.E., Stratton,M.S., Lillico,A.J., Fakih,M., Natarajan,R., Clark,L.C. and Marshall,J.R. (2004) A report of high dose selenium supplementation: response and toxicities. Trace Elements Med. 18, 69-74.
46. Hunt,T., Luca,F.C. and Ruderman,J.V. (1992) The requirements for protein synthesis and degradation and the control of destruction of cyclins A and B in the meiotic and mitotic cell cycles of the clam embryo. J. Cell. Biol., 116, 707-724.
47. Shin,H.J., Baek,K.H., Jeon,A.H., Kim,S.J., Jang,K.L., Sung,Y.C., Kim,C.M. and Lee,C.W. (2003) Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. Oncogene, 22, 3853-3858.
48. Su,T.T. and Jaklevic,B. (2001) DNA damage leads to a Cyclin A-dependent delay in metaphase-anaphase transition in the Drosophila gastrula. Curr. Biol., 11, 8-17.
49. Tinker-Kulberg,R.L. and Morgan,D.O. (1999) Pds1 and Esp1 control both anaphase and mitotic exit in normal cells and after DNA damage. Genes Dev., 13, 1936-1949.
50. Walter,S.A., Guadagno,S.N. and Ferrell,J.E. Jr (2000) Activation of Wee1 by p42 MAPK in vitro and in cycling xenopus egg extracts. Mol. Biol. Cell., 11, 887-896.
51. Liu,F., Rothblum-Oviatt,C., Ryan,C.E. and Piwnica-Worms,H. (1999) Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes. Mol. Cell. Biol., 19, 5113-5123.
52. Wells,N.J., Watanabe,N., Tokusumi,T., Jiang,W., Verdecia,M.A. and Hunter,T. (1999) The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G (2)/M progression. J. Cell. Sci., 112 (Pt 19), 3361-3371.
53. Chow,J.P., Siu,W.Y., Fung,T.K., Chan,W.M., Lau,A., Arooz,T., Ng,C.P., Yamashita,K. and Poon,R.Y. (2003) DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes and reverses cells to interphase. Mol. Biol. Cell, 14 3989-4002.
54. Pumiglia,K.M. and Decker,S.J. (1997) Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl Acad. Sci. USA, 94, 448-452.
55. Yan,G.Z. and Ziff, E.B. (1997) Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J. Neurosci., 17, 6122-6132.
56. Thomson,S., Clayton,A.L., Hazzalin,C.A., Rose,S., Barratt,M.J. and Mahadevan,L.C. (1999) The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J., 18, 4779-4793.
57. Yamamoto, Y., Verma,U.N., Prajapati,S., Kwak,Y.T. and Gaynor,R.B. (2003) Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature, 423, 655-659.